{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T11:44:43Z","timestamp":1782301483981,"version":"3.54.5"},"reference-count":9,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:00:00Z","timestamp":1704326400000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Erdheim\u2013Chester disease (ECD) is a rare multisystem disorder that primarily affects adults. It is characterized by the excessive production and accumulation of histiocytes, a type of white blood cell, within multiple tissues and organs, including the cardiovascular system. The infiltration of histiocytes can cause a range of cardiovascular symptoms, including pericardial effusion, myocardial infiltration, and heart failure, among others. Despite the potential severity of these cardiovascular manifestations, ECD is often misdiagnosed or underdiagnosed, leading to delays in appropriate treatment and poor outcomes for patients. As such, there is a pressing need for increased awareness and understanding of ECD\u2019s cardiovascular manifestations among clinicians and researchers. This article aims to highlight the importance of considering ECD as a potential underlying cause of cardiovascular complaints and to encourage further investigation into this uncommon but potentially life-threatening condition.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Case summary<\/jats:title>\n                  <jats:p>A 63-year-old man presented as outpatient complaining of dyspnoea on exertion during the last 3 weeks (New York Heart Association functional class III). He had also experienced a left shoulder and bilateral knee pain over the last 6 months. The patient was found to have a massive pericardial effusion associated with ECD. While pericardial effusions can have various causes, including infection, cancer, and autoimmune disorders, ECD is one potential cause of this condition. Therefore, it is important for clinicians to consider ECD in the differential diagnosis of patients presenting with unexplained pericardial effusions, particularly in the context of other systemic symptoms suggestive of ECD. We discuss about this specific aetiology and the clinical management of this uncommon condition.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>Erdheim\u2013Chester disease, a non-Langerhans cell histiocytosis, is a rare multisystem disorder. Diagnosis is challenging and should be suspected in the presence of a pericardial effusion with conduction abnormalities with indicators of a multisystem disease.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ehjcr\/ytae002","type":"journal-article","created":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T19:49:29Z","timestamp":1704397769000},"source":"Crossref","is-referenced-by-count":3,"title":["A rare case report of Erdheim\u2013Chester disease with pericardial effusion, conduction abnormalities, and atrial infiltration"],"prefix":"10.1093","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4674-6409","authenticated-orcid":false,"given":"Charaf","family":"Yassine","sequence":"first","affiliation":[{"name":"Department of Cardiology, Saint-Joseph Clinic , Route de Lennik 808, Brussels , Belgium {C}%3C!%2D%2D%7C%7CrmComment%7C%7C%3C~show%20%5BAQ%20ID%3DAQ4%5D~%3E%2D%2D%3E"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Colletti","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Saint-Joseph Clinic , Route de Lennik 808, Brussels , Belgium {C}%3C!%2D%2D%7C%7CrmComment%7C%7C%3C~show%20%5BAQ%20ID%3DAQ4%5D~%3E%2D%2D%3E"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Acasandrei","family":"Ciprian","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Saint-Joseph Clinic , Route de Lennik 808, Brussels , Belgium {C}%3C!%2D%2D%7C%7CrmComment%7C%7C%3C~show%20%5BAQ%20ID%3DAQ4%5D~%3E%2D%2D%3E"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mairesse","family":"George","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Saint-Joseph Clinic , Route de Lennik 808, Brussels , Belgium {C}%3C!%2D%2D%7C%7CrmComment%7C%7C%3C~show%20%5BAQ%20ID%3DAQ4%5D~%3E%2D%2D%3E"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,1,4]]},"reference":[{"key":"2024011909242232200_ytae002-B1","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1182\/blood-2014-03-561381","article-title":"Consensus guidelines for the diagnosis and clinical management of Erdheim\u2013Chester disease","volume":"124","author":"Diamond","year":"2014","journal-title":"Blood"},{"key":"2024011909242232200_ytae002-B2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00005792-199605000-00005","article-title":"Erdheim\u2013Chester disease: clinical and radiologic characteristics of 59 cases","volume":"75","author":"Veyssier-Belot","year":"1996","journal-title":"Medicine (Baltimore)"},{"key":"2024011909242232200_ytae002-B3","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1182\/blood-2012-05-430140","article-title":"High prevalence of BRAF V600E mutations in Erdheim\u2013Chester disease but not in other non-Langerhans cell histiocytoses","volume":"120","author":"Haroche","year":"2012","journal-title":"Blood"},{"key":"2024011909242232200_ytae002-B4","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1038\/s41375-020-0944-4","article-title":"Erdheim\u2013Chester disease: a rapidly evolving disease model","volume":"34","author":"Francesco","year":"2020","journal-title":"Leukemia"},{"key":"2024011909242232200_ytae002-B5","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/modpathol.2017.160","article-title":"The histopathology of Erdheim\u2013Chester disease: a comprehensive review of a molecularly characterized cohort","volume":"31","author":"Ozkaya","year":"2018","journal-title":"Mod Pathol"},{"key":"2024011909242232200_ytae002-B6","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1182\/blood-2012-07-446286","article-title":"Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim\u2013Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation","volume":"121","author":"Haroche","year":"2013","journal-title":"Blood"},{"key":"2024011909242232200_ytae002-B7","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1200\/JCO.2014.57.1950","article-title":"Reproducible and sustained efficacy of targeted therapy with vemurafenib in patients with BRAF(V600E)-mutated Erdheim\u2013Chester disease","volume":"33","author":"Haroche","year":"2015","journal-title":"J Clin Oncol"},{"key":"2024011909242232200_ytae002-B8","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1182\/blood-2017-03-771873","article-title":"Targeted therapies in 54 patients with Erdheim\u2013Chester disease, including follow-up after interruption (the LOVE study)","volume":"130","author":"Cohen","year":"2017","journal-title":"Blood"},{"key":"2024011909242232200_ytae002-B9","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1182\/blood-2010-06-294108","article-title":"CNS involvement and treatment with interferon-\u03b1 are independent prognostic factors in Erdheim\u2013Chester disease: a multicenter survival analysis of 53 patients","volume":"117","author":"Arnaud","year":"2011","journal-title":"Blood"}],"container-title":["European Heart Journal - Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcr\/advance-article-pdf\/doi\/10.1093\/ehjcr\/ytae002\/55029684\/ytae002.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/8\/1\/ytae002\/56246869\/ytae002.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/8\/1\/ytae002\/56246869\/ytae002.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T09:26:14Z","timestamp":1705656374000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcr\/article\/doi\/10.1093\/ehjcr\/ytae002\/7510957"}},"subtitle":[],"editor":[{"given":"Harry","family":"Klimis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Sumit","family":"Sohal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Edgar Francisco Carrizales","family":"Sepulveda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Franca","family":"Morselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,12,21]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,12,21]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcr\/ytae002","relation":{},"ISSN":["2514-2119"],"issn-type":[{"value":"2514-2119","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,1]]},"published":{"date-parts":[[2023,12,21]]},"article-number":"ytae002"}}